Type C botulinum toxin causes degeneration of motoneurons in vivo

Neuroreport. 2010 Jan 6;21(1):14-18. doi: 10.1097/WNR.0b013e328330dcca.

Abstract

All botulinum toxins (BoNTs, types A-G) inhibit synaptic transmitter release from motoneurons, and thus result in respiratory arrest and death. Rapid treatment with anti-BoNT antibodies can prevent progression, but recovery still requires weeks on a ventilator. Even after recovery, there is a potential for persistent fatigue in some cases of botulism even years after the insult, possibly because of motoneuron dropout for previously unknown reasons. Unique among BoNTs, the C-type (BoNT/C) cleaves two proteins involved in neurotransmitter release, syntaxin and SNAP-25, and induces apoptotic cell death in cultured cerebellar neurons. It is not clear, however, whether BoNT/C also affects neurons that encounter toxin in vivo, namely motoneurons. Here, we provide experimental evidence that BoNT/C causes a slow degeneration of motoneurons both in vitro and in vivo. This novel form of BoNT/C-induced cell death may require new treatment strategies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Botulinum Toxins / toxicity*
  • Cell Count / methods
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Functional Laterality
  • Group II Phospholipases A2
  • Indoles
  • Mice
  • Mice, Inbred C57BL
  • Motor Neurons / drug effects*
  • Nerve Degeneration / chemically induced*
  • Nerve Degeneration / pathology*
  • Neurofilament Proteins / metabolism
  • Poisons / toxicity*
  • Spinal Cord / cytology

Substances

  • Indoles
  • Neurofilament Proteins
  • Poisons
  • neurofilament protein H
  • DAPI
  • Group II Phospholipases A2
  • Botulinum Toxins
  • botulinum toxin type C